FUROSEMIDE Side Effects

6814701-9 | Atrial Fibrillation, Dizziness, Electrocardiogram Qt Prolonged, Electrocardiogram R On T Phenomenon, Electrocardiogram St Segment Abnormal, Hypokalaemia, Hypomagnesaemia, Loss Of Consciousness, Road Traffic Accident
on Jun 18, 2010 Female patient from CANADA , 64 years of age, was treated with Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), dizziness (What is dizziness?), electrocardiogram qt prolonged, electrocardiogram r on t phenomenon, electrocardiogram st segment abnormal, hypokalaemia, hypomagnesaemia, loss of consciousness, road traffic accident. Furosemide dosage: 40 Mg Od. During the same period patient was treated with METFORMIN HCL (1000 Mg Bid) (View Metformin Hcl Review and Metformin Hcl Label ), IRBESARTAN (150 Mg Bid) (View Irbesartan Review and Irbesartan Label ), DIGOXIN (0.25 Mg Od) (View Digoxin Review and Digoxin Label ), METALAZONE (2.5 Mg, 1 In 1 D) (View Metalazone Review and Metalazone Label ), GLYBURIDE (10 Mg, 2 In 1 D) (View Glyburide Review and Glyburide Label ), VENLAFAXINE (112.5 Mg, 1 In 1 D) (View Venlafaxine Review and Venlafaxine Label ), LEVOTHYROXINE SODIUM (200 Mcg, 1 In 1 D) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), OMEPRAZOLE (20 Mg, 1 In 1 D) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6812019-1 | Grand Mal Convulsion, Skin Ulcer
Patient was taking Furosemide (View Usage). Patient had the following side effects: grand mal convulsion, skin ulcer on Jun 25, 2010 from Additional patient health information: Female patient , 81 years of age, . Furosemide dosage: . During the same period patient was treated with ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LYSINE ASPIRIN (View Lysine Aspirin Review and Lysine Aspirin Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ). Patient was hospitalized.

6800582-6 | Blood Creatinine Increased, Blood Urea Increased
Adverse event was reported on Jun 25, 2010 by a Male patient taking Furosemide (View Usage) (Dosage: 80 Mg Every Day Po) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 73 years of age, After Furosemide was administered, patient had the following side effects: blood creatinine increased, blood urea increased. Patient was hospitalized.

6787947-6 | Abdominal Distension, Aortic Stenosis, Back Pain, Cardiac Arrest, Cardiac Failure, Cardiac Murmur, Cardiomegaly, Chronic Obstructive Pulmonary Disease
on Jun 04, 2010 Female patient from UNITED STATES , 72 years of age, weighting 173.5 lb, was diagnosed with oedema peripheral, arthritis (What is arthritis?), hypertension, insomnia, back pain (What is back pain?), depression (What is depression?), restless legs syndrome and was treated with Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, aortic stenosis, back pain (What is back pain?), cardiac arrest (What is cardiac arrest?), cardiac failure, cardiac murmur, cardiomegaly, chronic obstructive pulmonary disease. Furosemide dosage: Oral. During the same period patient was treated with ATORVASTATIN CALCIUM (40 Mg, 2 In 1d) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CELECOXIB (400 Mg, 2 In 1 D, Oral) (View Celecoxib Review and Celecoxib Label ), AMLODIPINE BESYLATE (Oral) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), VERAPAMIL (240 Mg, 1 In 1 D, Oral) (View Verapamil Review and Verapamil Label ), TRAZODONE HYDROCHLORIDE (150 Mg, 1 In 1 D, Oral) (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), HYDROCODONE HYDROCHLORIDE (30, 4 In 1 D) (View Hydrocodone Hydrochloride Review and Hydrocodone Hydrochloride Label ), FLUOXETINE (20, 1 In 1 D, Oral) (View Fluoxetine Review and Fluoxetine Label ), PRAMIPEXOLE (0.5, 2 In 1 D, Oral) (View Pramipexole Review and Pramipexole Label ). Patient was hospitalized.


6786047-9 | Hypotension, Polyuria
on Jun 21, 2010 Male patient from UNITED STATES , 72 years of age, weighting 302.0 lb, was diagnosed with cardiac failure congestive and was treated with Furosemide (View Usage). Patient had the following side effects: hypotension, polyuria. Furosemide dosage: 40 Mg Every Day Po. Patient was hospitalized.

6785782-6 | Cardiac Failure Congestive, Dysuria, Urine Output Decreased
Patient was taking Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: cardiac failure congestive, dysuria, urine output decreased on Jun 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 170.0 lb, was diagnosed with cardiac failure congestive, coronary artery disease (What is coronary artery disease?), hypertension, prostate cancer (What is prostate cancer?) and. Furosemide dosage: 20 Mg Every Other Day Po (approx 3-4 Years Ago For 2-3 Months).

6783411-9 | Atrial Tachycardia, Hypertension, Premature Labour, Pulmonary Oedema
Adverse event was reported on Jun 17, 2010 by a Female patient taking Furosemide (View Usage) (Dosage: ) was diagnosed with hypertension, atrial tachycardia and. Location: , 23 years of age, Patient experienced the following unwanted or unexpected effects: atrial tachycardia, hypertension, premature labour, pulmonary oedema. During the same period patient was treated with HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), LANATOSIDE C (View Lanatoside C Review and Lanatoside C Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6781100-8 | Fluid Intake Reduced, Renal Failure Acute
on Jun 17, 2010 Male patient from UNITED STATES , 89 years of age, weighting 177.0 lb, was diagnosed with cardiac failure congestive and was treated with Furosemide (View Usage). Patient had the following side effects: fluid intake reduced, renal failure acute. Furosemide dosage: 20 Mg Every Day Po. Patient was hospitalized.

6779488-7 | Malaise, Pneumonitis, Respiratory Failure
on Apr 07, 2010 Female patient from JAPAN , 82 years of age, weighting 143.3 lb, was diagnosed with hypertension and was treated with Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: malaise, pneumonitis, respiratory failure. Furosemide dosage: . During the same period patient was treated with AMLODIN (View Amlodin Review and Amlodin Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), ALTAT (View Altat Review and Altat Label ), BLOPRESS (View Blopress Review and Blopress Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6765186-2 | Acute Respiratory Failure, Renal Failure Acute
Patient was taking Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, renal failure acute on Jun 10, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 217.0 lb, was diagnosed with cardiac failure, pain in extremity and. Furosemide dosage: 80 Mg Three Times Daily Po Started Several Years Ago. During the same period patient was treated with KETOROLAC 10 MG NOT AVAILABLE (10 Mg Every 6 Hours Po) (View Ketorolac 10 Mg Not Available Review and Ketorolac 10 Mg Not Available Label ). Patient was hospitalized.

6752903-0 | Hypokalaemia
Adverse event was reported on Jun 02, 2010 by a Female patient taking Furosemide (View Usage) (Dosage: 40 Mg Bid Po) was diagnosed with cardiac failure congestive, hypertension and. Location: UNITED STATES , 44 years of age, weighting 161.6 lb, Patient had the following side effects: hypokalaemia. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg Every Day Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6743492-5 | Syncope
on May 21, 2010 Female patient from ITALY , 70 years of age, was treated with Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: syncope. Furosemide dosage: . During the same period patient was treated with LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), AMIODARONE (Dose:1 Unit(s)) (View Amiodarone Review and Amiodarone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), FLUTICASONE PROPIONATE/SALMETEROL (View Fluticasone Propionate/salmeterol Review and Fluticasone Propionate/salmeterol Label ). Patient was hospitalized.

6743463-9 | Blister, Heart Rate Increased, Hyperthermia
on May 17, 2010 Female patient from DENMARK , 18 years of age, was diagnosed with mycoplasma infection and was treated with Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: blister, heart rate increased, hyperthermia. Furosemide dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), DALTEPARIN SODIUM (View Dalteparin Sodium Review and Dalteparin Sodium Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6743186-6 | Blister, Heart Rate Increased, Hyperthermia
Patient was taking Furosemide (View Usage). Patient had the following side effects: blister, heart rate increased, hyperthermia on May 24, 2010 from Additional patient health information: Female patient , 18 years of age, was diagnosed with mycoplasma infection and. Furosemide dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6742045-2 | Lumbar Vertebral Fracture
Adverse event was reported on May 14, 2010 by a Female patient taking Furosemide (View Usage) (Dosage: ) . Location: GREECE , 85 years of age, After Furosemide was administered, patient had the following side effects: lumbar vertebral fracture. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIGITALIS TAB (View Digitalis Tab Review and Digitalis Tab Label ).

6742029-4 | Condition Aggravated, Dehydration, Psychotic Disorder, Renal Failure Acute
on May 06, 2010 Female patient from UNITED KINGDOM , 55 years of age, was treated with Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, dehydration, psychotic disorder (What is psychotic disorder?), renal failure acute. Furosemide dosage: . During the same period patient was treated with RISPSRIDONE (RISPERIDONE) (RISPERIDONE) (View Rispsridone (risperidone) (risperidone) Review and Rispsridone (risperidone) (risperidone) Label ), FERROUS SULPHATE (FERROUS SULFATE) (FERROUS SULFATE) (View Ferrous Sulphate (ferrous Sulfate) (ferrous Sulfate) Review and Ferrous Sulphate (ferrous Sulfate) (ferrous Sulfate) Label ), INSULIN (INSULIN) (INSULIN) (View Insulin (insulin) (insulin) Review and Insulin (insulin) (insulin) Label ), LEVOTHYROXINE (LEVOTHYROXINE) (LEVOTHYROXINE) (View Levothyroxine (levothyroxine) (levothyroxine) Review and Levothyroxine (levothyroxine) (levothyroxine) Label ), NORETHISTERONE (NORETHISTERONE) (NORETHISTERONE) (View Norethisterone (norethisterone) (norethisterone) Review and Norethisterone (norethisterone) (norethisterone) Label ), PROCYCLIDINE (PROCYCLIDINE) (PROCYCLIDINE) (View Procyclidine (procyclidine) (procyclidine) Review and Procyclidine (procyclidine) (procyclidine) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6733592-8 | Gynaecomastia
on May 19, 2010 Male patient from , 23 years of age, was diagnosed with rheumatic heart disease, mitral valve stenosis, tricuspid valve incompetence, atrial fibrillation (What is atrial fibrillation?) and was treated with Furosemide (View Usage). Patient had the following side effects: gynaecomastia. Furosemide dosage: 40 Mg. During the same period patient was treated with DIGOXIN (0.25 Mg) (View Digoxin Review and Digoxin Label ).

6731712-2 | Angioedema, Dysphagia, Dyspnoea, Respiratory Distress, Stridor
Patient was taking Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: angioedema, dysphagia, dyspnoea, respiratory distress, stridor on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 74 years of age, was diagnosed with oedema and. Furosemide dosage: 20mg Daily Po. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), MULTIVIT (View Multivit Review and Multivit Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6730819-3 | Blood Creatinine Increased, Blood Urea Increased, Lichenoid Keratosis
Adverse event was reported on May 04, 2010 by a Female patient taking Furosemide (View Usage) (Dosage: ) was diagnosed with renal failure chronic and. Location: SPAIN , 65 years of age, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, lichenoid keratosis. During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6727721-X | Cardiac Arrest, Electromechanical Dissociation, Hyperkalaemia, Hypokalaemia, Hypomagnesaemia, Impaired Healing, Oedema Peripheral, Pleural Effusion
on Apr 12, 2010 Female patient from UNITED KINGDOM , 77 years of age, was diagnosed with oedema peripheral, wound infection and was treated with Furosemide (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), electromechanical dissociation, hyperkalaemia, hypokalaemia, hypomagnesaemia, impaired healing, oedema peripheral, pleural effusion. Furosemide dosage: Oral. During the same period patient was treated with VANCOMYCIN (2 Gm, 2 In 1 D, Intravenous) (View Vancomycin Review and Vancomycin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), AMILORIDE HYDROCHLORIDE (View Amiloride Hydrochloride Review and Amiloride Hydrochloride Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6724494-1 | Psychotic Disorder, Renal Failure Chronic
on Apr 29, 2010 Female patient from UNITED KINGDOM , 55 years of age, weighting 229.3 lb, was diagnosed with schizophrenia, paranoid type, iron deficiency anaemia, diabetes mellitus, hypothyroidism, reproductive tract disorder, extrapyramidal disorder, hypercholesterolaemia and was treated with Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?), renal failure chronic. Furosemide dosage: . During the same period patient was treated with RISPERDAL CONSTA (View Risperdal Consta Review and Risperdal Consta Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), INSULIN (View Insulin Review and Insulin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NORETHISTERONE (View Norethisterone Review and Norethisterone Label ), PROCYCLIDINE HYDROCHLORIDE 2MG TAB (View Procyclidine Hydrochloride 2mg Tab Review and Procyclidine Hydrochloride 2mg Tab Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6721507-8 | Lumbar Vertebral Fracture
Patient was taking Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: lumbar vertebral fracture on May 03, 2010 from GREECE Additional patient health information: Female patient , 85 years of age, . Furosemide dosage: . During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), SINTROM (View Sintrom Review and Sintrom Label ), DIGITALIS TAB (View Digitalis Tab Review and Digitalis Tab Label ).

6720892-0 | Condition Aggravated, Granulomatous Liver Disease, Hypercalcaemia
Adverse event was reported on Apr 27, 2010 by a Male patient taking Furosemide (View Usage) (Dosage: 0.118 Mg/ml) was diagnosed with hypercalcaemia and. Location: SPAIN , 62 years of age, Patient had the following side effects: condition aggravated, granulomatous liver disease, hypercalcaemia. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6720032-8 | Blood Pressure Decreased, Bradycardia, Electrocardiogram Qt Prolonged, Hypocalcaemia, Hypokalaemia, Hyponatraemia, Incorrect Dose Administered, Pupil Fixed, Pupillary Reflex Impaired
on Apr 23, 2010 Female patient from TURKEY , 23 years of age, was treated with Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: blood pressure decreased, bradycardia, electrocardiogram qt prolonged, hypocalcaemia, hypokalaemia, hyponatraemia, incorrect dose administered, pupil fixed, pupillary reflex impaired. Furosemide dosage: Oral. During the same period patient was treated with FEXOFENADINE (Oral) (View Fexofenadine Review and Fexofenadine Label ). Patient was hospitalized.

6717183-0 | Renal Failure Acute
on Apr 28, 2010 Female patient from UNITED KINGDOM , 55 years of age, weighting 229.7 lb, was diagnosed with iron deficiency anaemia, hypothyroidism, reproductive tract disorder and was treated with Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Furosemide dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), INSULIN (View Insulin Review and Insulin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NORETHISTERONE (View Norethisterone Review and Norethisterone Label ), PROCYCLIDINE HYDROCHLORIDE 2MG TAB (View Procyclidine Hydrochloride 2mg Tab Review and Procyclidine Hydrochloride 2mg Tab Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6714857-2 | Acute Prerenal Failure, Condition Aggravated, Dehydration, Nephrolithiasis, Psychotic Disorder, Renal Failure Chronic
Patient was taking Furosemide (View Usage). Patient had the following side effects: acute prerenal failure, condition aggravated, dehydration, nephrolithiasis, psychotic disorder (What is psychotic disorder?), renal failure chronic on Apr 28, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 55 years of age, weighting 229.7 lb, was diagnosed with schizophrenia, paranoid type and. Furosemide dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

6712298-5 | Faecaloma
Adverse event was reported on Apr 21, 2010 by a Female patient taking Furosemide (View Usage) (Dosage: ) was diagnosed with hypertension, pain (What is pain?), dry eye, prophylaxis against gastrointestinal ulcer, hyperuricaemia and. Location: GERMANY , 93 years of age, After Furosemide was administered, patient had the following side effects: faecaloma. During the same period patient was treated with FENTANYL HEXAL (View Fentanyl Hexal Review and Fentanyl Hexal Label ), SICCAPOS /01282201/ (Linkes Und Rechtes Auge) (View Siccapos /01282201/ Review and Siccapos /01282201/ Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), OMEP (View Omep Review and Omep Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

6711678-1 | Lichenoid Keratosis
on May 04, 2010 Male patient from , 65 years of age, was diagnosed with renal failure chronic and was treated with Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: lichenoid keratosis. Furosemide dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCIUM (View Calcium Review and Calcium Label ).

6711451-4 | Hypovolaemia, Syncope
on May 04, 2010 Male patient from UNITED STATES , 88 years of age, weighting 152.1 lb, was diagnosed with hypertension and was treated with Furosemide (View Usage). Patient had the following side effects: hypovolaemia, syncope. Furosemide dosage: 20 Mg Bid Po. Patient was hospitalized.

6709134-X | Dizziness, Hypokalaemia
Patient was taking Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: dizziness (What is dizziness?), hypokalaemia on May 03, 2010 from UNITED STATES Additional patient health information: Male patient , 85 years of age, weighting 155.0 lb, was diagnosed with cardiac failure congestive, benign prostatic hyperplasia and. Furosemide dosage: 20 Mg Every Day Po. During the same period patient was treated with TERAZOSIN HCL (5 Mg Hs Po) (View Terazosin Hcl Review and Terazosin Hcl Label ). Patient was hospitalized.

6709122-3 | Syncope
Adverse event was reported on May 03, 2010 by a Male patient taking Furosemide (View Usage) (Dosage: 40 Mg Bid Po) was diagnosed with hypertension and. Location: UNITED STATES , 81 years of age, weighting 204.8 lb, Patient experienced the following unwanted or unexpected effects: syncope. Patient was hospitalized.

6706153-4 | Abdominal Pain, Constipation, Dehydration, Faecaloma, Gastrointestinal Motility Disorder
on Apr 22, 2010 Female patient from GERMANY , 93 years of age, was diagnosed with dry eye, hyperuricaemia and was treated with Furosemide (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), dehydration, faecaloma, gastrointestinal motility disorder. Furosemide dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), SICCAPOS GEL (Left And Right Eye) (View Siccapos Gel Review and Siccapos Gel Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), OMEP (View Omep Review and Omep Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

6704437-7 | Faecaloma
on Apr 21, 2010 Female patient from GERMANY , 93 years of age, was diagnosed with hypertension, pain (What is pain?) and was treated with Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: faecaloma. Furosemide dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ). Patient was hospitalized.

6702087-X | Pulmonary Fibrosis
Patient was taking Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary fibrosis (What is pulmonary fibrosis?) on Apr 20, 2010 from FRANCE Additional patient health information: Male patient , 72 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Furosemide dosage: . During the same period patient was treated with PENTASA (View Pentasa Review and Pentasa Label ), SODIUM ALGINATE/SODIUM BICARBONATE (View Sodium Alginate/sodium Bicarbonate Review and Sodium Alginate/sodium Bicarbonate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), APRANAX (View Apranax Review and Apranax Label ), PARACETAMOL AND CAFFEINE AND ATROPA BELLADONNA EXTRACT AND PAPAVER SOM (View Paracetamol And Caffeine And Atropa Belladonna Extract And Papaver Som Review and Paracetamol And Caffeine And Atropa Belladonna Extract And Papaver Som Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6700185-8 | Condition Aggravated, Respiratory Failure
Adverse event was reported on Apr 15, 2010 by a Male patient taking Furosemide (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 70 years of age, Patient had the following side effects: condition aggravated, respiratory failure. During the same period patient was treated with AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ).

6700154-8 | Cardiac Failure, Hyponatraemia, Respiratory Failure
on Apr 16, 2010 Female patient from SPAIN , 87 years of age, was diagnosed with osteoporosis (What is osteoporosis?), pain (What is pain?) and was treated with Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: cardiac failure, hyponatraemia, respiratory failure. Furosemide dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), LIDALTRIN DIU (View Lidaltrin Diu Review and Lidaltrin Diu Label ), CALCIUM D SANDOZ (View Calcium-d-sandoz Review and Calcium-d-sandoz Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ZALDIAR (View Zaldiar Review and Zaldiar Label ).

6700140-8 | Dehydration, Hypotension, Ischaemic Stroke
on Sep 16, 2009 Female patient from FRANCE , 85 years of age, was treated with Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, hypotension, ischaemic stroke. Furosemide dosage: Dose Unit: 40 Mg. During the same period patient was treated with RAMIPRIL (Dose Unit: 1.25 Mg) (View Ramipril Review and Ramipril Label ), KARDEGIC /FRA/ (Dose Unit: 75 Mg) (View Kardegic /fra/ Review and Kardegic /fra/ Label ), TAHOR (Dose Unit: 40 Mg) (View Tahor Review and Tahor Label ), OMEPRAZOLE (Dose Unit: 20 Mg) (View Omeprazole Review and Omeprazole Label ), SURBRONC (View Surbronc Review and Surbronc Label ), ENOXAPARIN SODIUM (Dose Unit: .4 Ml) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

6698333-1 | Cholestasis, Hepatic Enzyme Increased, International Normalised Ratio Abnormal, Jaundice, Ocular Icterus, Pruritus, Urine Colour Abnormal
Patient was taking Furosemide (View Usage). Patient had the following side effects: cholestasis, hepatic enzyme increased, international normalised ratio abnormal, jaundice (What is jaundice?), ocular icterus, pruritus, urine colour abnormal on Apr 26, 2010 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 232.8 lb, was diagnosed with hypertension, gout (What is gout?) and. Furosemide dosage: 40 Mg Am Po. During the same period patient was treated with PROBENECID (View Probenecid Review and Probenecid Label ). Patient was hospitalized.

6693057-9 | Cardiac Arrest, Hyperkalaemia, Hypokalaemia, Impaired Healing, Oedema Peripheral, Pleural Effusion, Ventricular Tachycardia
Adverse event was reported on Apr 21, 2010 by a Female patient taking Furosemide (View Usage) (Dosage: ) was diagnosed with oedema peripheral, hypertension, evidence based treatment, hypokalaemia and. Location: , 77 years of age, After Furosemide was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), hyperkalaemia, hypokalaemia, impaired healing, oedema peripheral, pleural effusion, ventricular tachycardia. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), VANCOMYCIN (2 G) (View Vancomycin Review and Vancomycin Label ), POTASSIUM (View Potassium Review and Potassium Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6686320-9 | Malaise, Pneumonitis, Respiratory Failure
on Apr 07, 2010 Female patient from JAPAN , 82 years of age, weighting 143.3 lb, was diagnosed with hypertension and was treated with Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, pneumonitis, respiratory failure. Furosemide dosage: . During the same period patient was treated with AMLODIN (View Amlodin Review and Amlodin Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), ALTAT (View Altat Review and Altat Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6672421-8 | Blood Potassium Increased, Cardiac Failure, Condition Aggravated, Hepatic Function Abnormal, Rhabdomyolysis
on Mar 25, 2010 Male patient from CHINA , 56 years of age, was treated with Furosemide (View Usage). Patient had the following side effects: blood potassium increased, cardiac failure, condition aggravated, hepatic function abnormal, rhabdomyolysis. Furosemide dosage: . During the same period patient was treated with ISONIAZIDE (ISONIAZID) (ISONIAZID) (View Isoniazide (isoniazid) (isoniazid) Review and Isoniazide (isoniazid) (isoniazid) Label ), HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) (HYDROCHLOROTHIZIDE) (View Hydrochlorothiazide (hydrochlorothiazide) (hydrochlorothizide) Review and Hydrochlorothiazide (hydrochlorothiazide) (hydrochlorothizide) Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LOSARTAN (LOSARTAN) (LOSARTAN) (View Losartan (losartan) (losartan) Review and Losartan (losartan) (losartan) Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ETHAMBUTOL (ETHAMBUTOL) (ETAMUBOTOL) (View Ethambutol (ethambutol) (etamubotol) Review and Ethambutol (ethambutol) (etamubotol) Label ), GLICLAZIDE (GLICLAZIDE) (GLICLAZIDE) (View Gliclazide (gliclazide) (gliclazide) Review and Gliclazide (gliclazide) (gliclazide) Label ), ACARBOSE (ACARBOSE) (ACARBOSE) (View Acarbose (acarbose) (acarbose) Review and Acarbose (acarbose) (acarbose) Label ). Patient was hospitalized.

6666839-7 | Syncope
Patient was taking Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: syncope on Apr 01, 2010 from UNITED STATES Additional patient health information: Male patient , 40 years of age, weighting 280.0 lb, was diagnosed with hypertension and. Furosemide dosage: 20 Mg Every Day Po. During the same period patient was treated with HYDROCHLOROTHIAZIDE (50 Mg Every Day Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6665544-0 | Osmotic Demyelination Syndrome, Parkinsonism
Adverse event was reported on Mar 24, 2010 by a Male patient taking Furosemide (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 62 years of age, Patient experienced the following unwanted or unexpected effects: osmotic demyelination syndrome, parkinsonism. During the same period patient was treated with SODIUM CHLORIDE/WATER (View Sodium Chloride/water Review and Sodium Chloride/water Label ), NATRIX (View Natrix Review and Natrix Label ).

6655284-6 | Coagulopathy, Disease Recurrence, Iga Nephropathy, Nephrotic Syndrome, Pemphigoid, Sepsis
on Mar 23, 2010 Male patient from , 52 years of age, was diagnosed with skin lesion, dermatitis bullous and was treated with Furosemide (View Usage). Patient had the following side effects: coagulopathy, disease recurrence, iga nephropathy, nephrotic syndrome, pemphigoid, sepsis (What is sepsis?). Furosemide dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLIC ACID (View Mycophenolic Acid Review and Mycophenolic Acid Label ), CLOBETASOL PROPIONATE (View Clobetasol Propionate Review and Clobetasol Propionate Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), DAPSONE (100 Mg) (View Dapsone Review and Dapsone Label ). Patient was hospitalized.

6649338-8 | Cardiac Murmur, Hypovolaemia, Left Ventricular Hypertrophy, Pericardial Effusion, Sinus Bradycardia, Syncope
on Mar 08, 2010 Male patient from UNITED STATES , 46 years of age, was diagnosed with oedema peripheral and was treated with Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: cardiac murmur, hypovolaemia, left ventricular hypertrophy, pericardial effusion, sinus bradycardia, syncope. Furosemide dosage: Intravenous.

6642244-4 | Dialysis, Renal Failure Acute
Patient was taking Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), renal failure acute on Mar 08, 2010 from UNITED STATES Additional patient health information: Male patient , 52 years of age, was diagnosed with oedema peripheral and. Furosemide dosage: 20 Mg/day, Then 60mg/day Injection Nos. During the same period patient was treated with LISINOPRIL (10mg/day) (View Lisinopril Review and Lisinopril Label ).

6638450-5 | Asthenia, Dysstasia
Adverse event was reported on Mar 16, 2010 by a Female patient taking Furosemide (View Usage) (Dosage: 1 Tab Every Morning) was diagnosed with joint swelling, oedema peripheral and. Location: UNITED STATES , 84 years of age, weighting 164.0 lb, Patient had the following side effects: asthenia, dysstasia. Patient was hospitalized.

6635992-3 | Electrocardiogram Qt Prolonged
on Mar 03, 2010 Female patient from UNITED STATES , 67 years of age, weighting 200.6 lb, was treated with Furosemide (View Usage). After Furosemide was administered, patient had the following side effects: electrocardiogram qt prolonged. Furosemide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), SITAGLIPTIN PHOSPHATE (View Sitagliptin Phosphate Review and Sitagliptin Phosphate Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), MIRAPEX ^PHARMACIA + UPJOHN^ (View Mirapex ^pharmacia + Upjohn^ Review and Mirapex ^pharmacia + Upjohn^ Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6635172-1 | Lichenoid Keratosis
on Mar 11, 2010 Male patient from , 56 years of age, was diagnosed with hypertension, mixed connective tissue disease, lichenoid keratosis and was treated with Furosemide (View Usage). Patient experienced the following unwanted or unexpected effects: lichenoid keratosis. Furosemide dosage: 40 Mg. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), IREBSARTAN HYDROCHLOROTHIAZIDE (View Irebsartan-hydrochlorothiazide Review and Irebsartan-hydrochlorothiazide Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), DESONIDE (View Desonide Review and Desonide Label ), CETIRIZINE (View Cetirizine Review and Cetirizine Label ).

6633011-6 | Electrocardiogram Qt Prolonged
Patient was taking Furosemide (View Usage). Patient had the following side effects: electrocardiogram qt prolonged on Mar 03, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, weighting 200.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Furosemide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), SITAGLIPTIN PHOSPHATE (View Sitagliptin Phosphate Review and Sitagliptin Phosphate Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), MIRAPEX ^PHARMACIA + UPJOHN^ (View Mirapex ^pharmacia + Upjohn^ Review and Mirapex ^pharmacia + Upjohn^ Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ).